Paolo Ascierto

Professor Ascierto is currently Director of the Unit of Melanoma, Cancer Immunotherapy, and Innovative therapy at that same institution. He is an active Scientific Reviewer for several international journals, including, JCO, Lancet Oncology, and Clinical Cancer Research, as well as being the Editor-in-Chief of the Combination Strategies section of the Journal of Translational Medicine and Chief Section Editor of Expert Reviews of Immunology Vaccines and Informatics. As a result of Professor Ascierto’s experience and expertise, he has been a valued invited speaker at more than 350 national and international meetings. Furthermore, he is an active member of the Italian Society of Medical Oncology (AIOM), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Organization for Research and Treatment of Cancer (EORTC), and Society of ImmunoTherapy of Cancer (SITC).

Professor Ascierto has presided as Principal Investigator on over 50 clinical trials and he is the author of numerous publications in peer-reviewed journals. Such journals include The New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology, and Clinical Cancer Research, among others.